$ANIK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anika Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anika Therapeutics, Inc.. Get notifications about new insider transactions in Anika Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.34 | 900 | 8,406 | 131,100 | 132 K to 131.1 K (-0.68 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.33 | 700 | 6,531 | 132,000 | 132.7 K to 132 K (-0.53 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.32 | 900 | 8,388 | 132,700 | 133.6 K to 132.7 K (-0.67 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.31 | 200 | 1,862 | 133,600 | 133.8 K to 133.6 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.30 | 750 | 6,975 | 133,800 | 134.6 K to 133.8 K (-0.56 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.29 | 300 | 2,787 | 134,550 | 134.9 K to 134.6 K (-0.22 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.28 | 550 | 5,104 | 134,850 | 135.4 K to 134.9 K (-0.41 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.27 | 900 | 8,343 | 135,400 | 136.3 K to 135.4 K (-0.66 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.26 | 1,000 | 9,260 | 136,300 | 137.3 K to 136.3 K (-0.73 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.25 | 1,500 | 13,875 | 137,300 | 138.8 K to 137.3 K (-1.08 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.24 | 340 | 3,142 | 138,800 | 139.1 K to 138.8 K (-0.24 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.23 | 400 | 3,692 | 139,140 | 139.5 K to 139.1 K (-0.29 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.22 | 100 | 922 | 139,540 | 139.6 K to 139.5 K (-0.07 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.21 | 200 | 1,842 | 139,640 | 139.8 K to 139.6 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.19 | 400 | 3,676 | 139,840 | 140.2 K to 139.8 K (-0.29 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.18 | 200 | 1,836 | 140,240 | 140.4 K to 140.2 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.17 | 700 | 6,419 | 140,440 | 141.1 K to 140.4 K (-0.50 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.16 | 960 | 8,794 | 141,140 | 142.1 K to 141.1 K (-0.68 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.11 | 200 | 1,822 | 142,100 | 142.3 K to 142.1 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.09 | 200 | 1,818 | 142,300 | 142.5 K to 142.3 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 5.25 | 15,000 | 78,750 | 142,500 | 127.5 K to 142.5 K (+11.76 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.99 | 300 | 2,997 | 127,500 | 127.8 K to 127.5 K (-0.23 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.98 | 200 | 1,996 | 127,800 | 128 K to 127.8 K (-0.16 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.97 | 200 | 1,994 | 128,000 | 128.2 K to 128 K (-0.16 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.96 | 400 | 3,984 | 128,200 | 128.6 K to 128.2 K (-0.31 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.95 | 300 | 2,985 | 128,600 | 128.9 K to 128.6 K (-0.23 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.91 | 100 | 991 | 128,900 | 129 K to 128.9 K (-0.08 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.89 | 300 | 2,967 | 129,000 | 129.3 K to 129 K (-0.23 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.88 | 300 | 2,964 | 129,300 | 129.6 K to 129.3 K (-0.23 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.87 | 400 | 3,948 | 129,600 | 130 K to 129.6 K (-0.31 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.85 | 600 | 5,910 | 130,000 | 130.6 K to 130 K (-0.46 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.84 | 400 | 3,936 | 130,600 | 131 K to 130.6 K (-0.31 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.83 | 500 | 4,915 | 131,000 | 131.5 K to 131 K (-0.38 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.82 | 909 | 8,926 | 131,500 | 132.4 K to 131.5 K (-0.69 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 5.25 | 15,000 | 78,750 | 30,000 | |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 5.25 | 15,000 | 78,750 | 15,000 | |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.81 | 100 | 981 | 132,409 | 132.5 K to 132.4 K (-0.08 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.79 | 200 | 1,958 | 132,509 | 132.7 K to 132.5 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.78 | 600 | 5,868 | 132,709 | 133.3 K to 132.7 K (-0.45 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.77 | 200 | 1,954 | 133,309 | 133.5 K to 133.3 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.76 | 200 | 1,952 | 133,509 | 133.7 K to 133.5 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.75 | 200 | 1,950 | 133,709 | 133.9 K to 133.7 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.74 | 200 | 1,948 | 133,909 | 134.1 K to 133.9 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.73 | 300 | 2,919 | 134,109 | 134.4 K to 134.1 K (-0.22 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.72 | 200 | 1,944 | 134,409 | 134.6 K to 134.4 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.71 | 200 | 1,942 | 134,609 | 134.8 K to 134.6 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.70 | 200 | 1,940 | 134,809 | 135 K to 134.8 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.69 | 700 | 6,783 | 135,009 | 135.7 K to 135 K (-0.52 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.68 | 200 | 1,936 | 135,709 | 135.9 K to 135.7 K (-0.15 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.67 | 500 | 4,835 | 135,909 | 136.4 K to 135.9 K (-0.37 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.66 | 100 | 966 | 136,409 | 136.5 K to 136.4 K (-0.07 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.65 | 600 | 5,790 | 136,509 | 137.1 K to 136.5 K (-0.44 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.64 | 700 | 6,748 | 137,109 | 137.8 K to 137.1 K (-0.51 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.63 | 500 | 4,815 | 137,809 | 138.3 K to 137.8 K (-0.36 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.62 | 600 | 5,772 | 138,309 | 138.9 K to 138.3 K (-0.43 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.60 | 400 | 3,840 | 138,909 | 139.3 K to 138.9 K (-0.29 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.59 | 200 | 1,918 | 139,309 | 139.5 K to 139.3 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.58 | 100 | 958 | 139,509 | 139.6 K to 139.5 K (-0.07 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.57 | 300 | 2,871 | 139,609 | 139.9 K to 139.6 K (-0.21 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.56 | 200 | 1,912 | 139,909 | 140.1 K to 139.9 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.55 | 991 | 9,464 | 140,109 | 141.1 K to 140.1 K (-0.70 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.54 | 400 | 3,816 | 141,100 | 141.5 K to 141.1 K (-0.28 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.53 | 400 | 3,812 | 141,500 | 141.9 K to 141.5 K (-0.28 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.52 | 200 | 1,904 | 141,900 | 142.1 K to 141.9 K (-0.14 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 9.47 | 400 | 3,788 | 142,100 | 142.5 K to 142.1 K (-0.28 %) |
| Mar 13 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 5.25 | 15,000 | 78,750 | 142,500 | 127.5 K to 142.5 K (+11.76 %) |
| Mar 12 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 9.80 | 500 | 4,900 | 1,000 | 500 to 1,000 (+100.00 %) |
| Mar 12 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Buy | P | 9.95 | 500 | 4,975 | 500 | 0 to 500 |
| Mar 12 2008 | ANIK | Anika Therapeutics ... | Mrachek William | V.P., Human Resourc ... | Buy | P | 9.16 | 500 | 4,580 | 1,600 | 1.1 K to 1.6 K (+45.45 %) |
| Feb 29 2008 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 7.63 | 2,000 | 15,250 | 2,000 | |
| Feb 29 2008 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Buy | M | 7.63 | 2,000 | 15,250 | 20,000 | 18 K to 20 K (+11.11 %) |
| Feb 28 2008 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 7.63 | 2,000 | 15,250 | 2,000 | |
| Feb 28 2008 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 7.63 | 2,000 | 15,250 | 60,920 | 58.9 K to 60.9 K (+3.39 %) |
| Feb 05 2008 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | A | 10.51 | 2,850 | 29,954 | 2,850 | |
| Feb 05 2008 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | A | 10.51 | 2,850 | 29,954 | 2,850 | |
| Feb 05 2008 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 10.51 | 2,850 | 29,954 | 2,850 | |
| Feb 05 2008 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | A | 10.51 | 2,850 | 29,954 | 0 | |
| Feb 05 2008 | ANIK | Anika Therapeutics ... | Moran John C | Director | Option Exercise | A | 10.51 | 2,850 | 29,954 | 2,850 | |
| Feb 04 2008 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 10.99 | 57,530 | 632,255 | 57,530 | |
| Feb 04 2008 | ANIK | Anika Therapeutics ... | QUINLAN KEVIN W | Chief Financial Off ... | Option Exercise | A | 10.99 | 20,570 | 226,064 | 20,570 | |
| Feb 04 2008 | ANIK | Anika Therapeutics ... | Mrachek William | Vice President Huma ... | Option Exercise | A | 10.99 | 13,080 | 143,749 | 13,080 | |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 1.05 | 3,250 | 3,413 | 8,550 | |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | M | 0.91 | 6,750 | 6,117 | 0 | |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.50 | 2,000 | 41,000 | 30,000 | 32 K to 30 K (-6.25 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.40 | 1,000 | 20,400 | 32,000 | 33 K to 32 K (-3.03 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.30 | 400 | 8,120 | 33,000 | 33.4 K to 33 K (-1.20 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.05 | 134 | 2,687 | 33,400 | 33.5 K to 33.4 K (-0.40 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.10 | 150 | 3,015 | 33,534 | 33.7 K to 33.5 K (-0.45 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.08 | 200 | 4,016 | 33,684 | 33.9 K to 33.7 K (-0.59 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.12 | 1,500 | 30,180 | 33,884 | 35.4 K to 33.9 K (-4.24 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.13 | 400 | 8,052 | 35,384 | 35.8 K to 35.4 K (-1.12 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.02 | 100 | 2,002 | 35,784 | 35.9 K to 35.8 K (-0.28 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.00 | 100 | 2,000 | 35,884 | 36 K to 35.9 K (-0.28 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 19.96 | 400 | 7,984 | 35,984 | 36.4 K to 36 K (-1.10 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.65 | 500 | 10,325 | 36,384 | 36.9 K to 36.4 K (-1.36 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.62 | 1,200 | 24,744 | 36,884 | 38.1 K to 36.9 K (-3.15 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.56 | 100 | 2,056 | 38,084 | 38.2 K to 38.1 K (-0.26 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.54 | 1,000 | 20,540 | 38,184 | 39.2 K to 38.2 K (-2.55 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.69 | 300 | 6,207 | 39,184 | 39.5 K to 39.2 K (-0.76 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.68 | 200 | 4,136 | 39,484 | 39.7 K to 39.5 K (-0.50 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.67 | 100 | 2,067 | 39,684 | 39.8 K to 39.7 K (-0.25 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Sell | S | 20.60 | 216 | 4,450 | 39,784 | 40 K to 39.8 K (-0.54 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 1.05 | 3,250 | 3,413 | 40,000 | 36.8 K to 40 K (+8.84 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Buy | M | 0.91 | 6,750 | 6,117 | 36,750 | 30 K to 36.8 K (+22.50 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Option Exercise | M | 1.17 | 10,000 | 11,700 | 102,500 | |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.00 | 2,700 | 54,000 | 127,500 | 130.2 K to 127.5 K (-2.07 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.01 | 100 | 2,001 | 130,200 | 130.3 K to 130.2 K (-0.08 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.04 | 800 | 16,032 | 130,300 | 131.1 K to 130.3 K (-0.61 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.02 | 200 | 4,004 | 131,100 | 131.3 K to 131.1 K (-0.15 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.05 | 1,000 | 20,050 | 131,300 | 132.3 K to 131.3 K (-0.76 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.07 | 100 | 2,007 | 132,300 | 132.4 K to 132.3 K (-0.08 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.08 | 100 | 2,008 | 132,400 | 132.5 K to 132.4 K (-0.08 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.00 | 4,600 | 92,000 | 132,500 | 137.1 K to 132.5 K (-3.36 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.01 | 100 | 2,001 | 137,100 | 137.2 K to 137.1 K (-0.07 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.02 | 100 | 2,002 | 137,200 | 137.3 K to 137.2 K (-0.07 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Sell | S | 20.06 | 200 | 4,012 | 137,300 | 137.5 K to 137.3 K (-0.15 %) |
| Jul 31 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.17 | 10,000 | 11,700 | 137,500 | 127.5 K to 137.5 K (+7.84 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Option Exercise | M | 3.92 | 15,000 | 58,800 | 5,000 | |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Option Exercise | M | 1.05 | 20,000 | 21,000 | 0 | |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Option Exercise | M | 6.16 | 15,000 | 92,340 | 0 | |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Option Exercise | M | 9.22 | 22,500 | 207,450 | 7,500 | |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Buy | M | 3.92 | 15,000 | 58,800 | 35,000 | 20 K to 35 K (+75.00 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Buy | M | 1.05 | 20,000 | 21,000 | 20,000 | 0 to 20 K |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.55 | 5,000 | 62,750 | 0 | 5 K to 0 (-100.00 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.80 | 1,735 | 22,208 | 5,000 | 6.7 K to 5 K (-25.76 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.75 | 2,500 | 31,875 | 6,735 | 9.2 K to 6.7 K (-27.07 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.85 | 5,400 | 69,390 | 9,235 | 14.6 K to 9.2 K (-36.90 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.84 | 600 | 7,704 | 14,635 | 15.2 K to 14.6 K (-3.94 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.60 | 300 | 3,780 | 15,235 | 15.5 K to 15.2 K (-1.93 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.50 | 610 | 7,625 | 15,535 | 16.1 K to 15.5 K (-3.78 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.46 | 200 | 2,492 | 16,145 | 16.3 K to 16.1 K (-1.22 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.35 | 3,690 | 45,572 | 16,345 | 20 K to 16.3 K (-18.42 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.39 | 100 | 1,239 | 20,035 | 20.1 K to 20 K (-0.50 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.40 | 10,000 | 124,000 | 20,135 | 30.1 K to 20.1 K (-33.18 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Sell | S | 12.45 | 7,365 | 91,694 | 30,135 | 37.5 K to 30.1 K (-19.64 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Buy | M | 6.16 | 15,000 | 92,340 | 37,500 | 22.5 K to 37.5 K (+66.67 %) |
| May 17 2007 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | Vice President of O ... | Buy | M | 9.22 | 22,500 | 207,450 | 22,500 | 0 to 22.5 K |
| Apr 09 2007 | ANIK | Anika Therapeutics ... | Mrachek William | V.P., Human Resourc ... | Option Exercise | A | 13.51 | 10,000 | 135,100 | 10,000 | |
| Jan 30 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.05 | 40,000 | 42,000 | 40,000 | 0 to 40 K |
| Jan 30 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.16 | 37,500 | 43,500 | 37,500 | 0 to 37.5 K |
| Jan 30 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.05 | 12,500 | 13,125 | 12,500 | 0 to 12.5 K |
| Jan 30 2007 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President & CEO | Buy | M | 1.17 | 37,500 | 43,875 | 37,500 | 0 to 37.5 K |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | LUPPINO FRANCESCO J | VP Operations | Option Exercise | A | 12.36 | 13,000 | 160,680 | 13,000 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | A | 12.36 | 1,540 | 19,034 | 1,540 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President and CEO | Option Exercise | A | 12.36 | 49,000 | 605,640 | 49,000 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Option Exercise | A | 12.36 | 1,540 | 19,034 | 1,540 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | DAVIDSON EUGENE A | Director | Option Exercise | A | 12.36 | 1,540 | 19,034 | 1,540 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | A | 12.36 | 1,540 | 19,034 | 1,540 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | Moran John C | Director | Option Exercise | A | 12.36 | 1,540 | 19,034 | 1,540 | |
| Dec 18 2006 | ANIK | Anika Therapeutics ... | Moran John C | Director | Option Exercise | A | 12.36 | 4,500 | 55,620 | 4,500 |